Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. on April 7, 2017, reporting a significant change in beneficial ownership effective as of that date. The filing details the sale of securities by the Alfred E. Mann Living Trust to a group of private investors, including Gregg G. Williams, a member of the Board of Directors.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. This report focuses exclusively on a transaction involving the transfer of equity securities.
Material Changes
- Transfer of Mann Trust Holdings: The Alfred E. Mann Living Trust sold 6,644,991 shares of common stock and warrants to purchase 360,000 additional shares to a group of private investors.
- Gregg G. Williams Acquisition: Gregg G. Williams acquired 4,000,000 shares and 216,705 warrants through his 2006 Trust as part of this transaction.
- Exhaustion of Mann Trust Holdings: The Company believes this transaction represents the Mann Trust's total remaining holdings of the Company's securities.
- Updated Beneficial Ownership: Following the transaction, Mr. Williams is deemed the beneficial owner of 19,367,848 shares, representing 34% of the Company's outstanding common shares.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, or specific operational risks. The primary disclosure relates to the change in control structure and the concentration of ownership with Mr. Williams, who also holds warrants to purchase 7,474,347 shares at various exercise prices ranging from $1.47 to $5.00 per share.
Investor Verification Checklist
- Verify the total number of outstanding shares to confirm the 34% ownership stake calculation for Gregg G. Williams.
- Review the terms of the warrants acquired by Mr. Williams, specifically the exercise prices ($1.47 and $5.00) and expiration dates.
- Confirm the status of the Mann Trust's remaining assets and any potential future transactions involving the late co-founder's estate.
- Check for any related proxy statements or Schedule 13D filings that may provide further detail on the "group of individual private investors."